Pgnx stocktwits

Find the latest Novavax, Inc. (NVAX) stock quote, history, news and other vital information to help you with your stock trading and investing. Progenics Pharmaceuticals (NASDAQ:PGNX) Earnings Information. Progenics Pharmaceuticals last announced its earnings data on November 7th, 2019. The biotechnology company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.24) by $0.02. Which institutional investors are buying and selling shares of Progenics Pharmaceuticals (NASDAQ:PGNX) stock? View the most recent institutional ownership activity and 13F transactions for PGNX stock at MarketBeat.

Current Technical Analysis and interactive chart for $MMAC stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals. Current Technical Analysis and interactive chart for $NPK stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals. At the moment the algo is monitoring 4200 underliers covering the following indices: Index Name Code SPX S&P 500 US DJIA Dow Jones Industrial Average US DAX Deutscher Aktien Index DE SX5E EURO Stoxx 50 EU ATX Austrian Traded Index AT HSI… Current Technical Analysis and interactive chart for $CIG stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals. Current Technical Analysis and interactive chart for $PSF stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals. Current Technical Analysis and interactive chart for $OLED stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.

19 hours ago Shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) passed above its 200-day moving average during trading on Wednesday .

8/1/2018 · Progenics Pharmaceuticals received a critical approval from the FDA on Monday. The shares have dropped some 10% since then in some buy the rumor, sell the news At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that 12/17/2019 · Progenics Pharmaceuticals Inc. Common Stock (PGNX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global Progenics' pipeline includes products in pre-clinical - late-stage development. We're focused on critical unmet diagnostic/therapeutic cancer patients needs

Progenics Pharmaceuticals (NASDAQ:PGNX) Earnings Information. Progenics Pharmaceuticals last announced its earnings data on November 7th, 2019. The biotechnology company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.24) by $0.02.

Which institutional investors are buying and selling shares of Progenics Pharmaceuticals (NASDAQ:PGNX) stock? View the most recent institutional ownership activity and 13F transactions for PGNX stock at MarketBeat.

Filing Date T Date Ticker Sector Ind Industry Owner oSt Rel Title T TVal Price L Qty oc Own H r2y r1y r6m r3m r6w r3w r7d r3d f1d f1w f1m f3m f6m f1y

Sep 15, 2017 Biohaven Pharmaceutical (BHVN) and Progenics Pharmaceuticals (PGNX) may be attracting the interest of 18 pharmaceuticals apiece. recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits). PGNX, Buy 

Current Technical Analysis and interactive chart for $PROS stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals.

8/9/2019 · Find the latest Progenics Pharmaceuticals Inc. (PGNX) stock quote, history, news and other vital information to help you with your stock trading and investing. 12/31/2019 · PGNX closed up 0.2 percent on Tuesday, December 31, 2019, on 75 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected. Progenics (PGNX) Reports Q3 Loss, Lags Revenue Estimates Progenics (PGNX) delivered earnings and revenue surprises of 18.52% and -20.35%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

PGNX closed up 4.79 percent on Friday, September 27, 2019, on approximately normal volume. The bulls were able to push the stock to a new 52-week high. 12/20/2018 · Find the latest on option chains for Progenics Pharmaceuticals Inc. Common Stock (PGNX) at Nasdaq.com. Drugs Associated with Progenics Pharmaceuticals, Inc. Progenics Pharmaceuticals, Inc. manufactures, markets and/or distributes 1 drug in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.